1 of 1
Story summary
- Wegovy will launch in the UK at a 7.2 mg dose, approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
- The 7.2 mg dose is a single-dose option that replaces the prior triple-dose regimen.
- Clinical trials showed participants lost an average of 20.7% of body weight over 72 weeks, with gastrointestinal side effects noted.
- Eli Lilly's Foundayo also showed success, with Maggie Linton losing 60 pounds in two years.
